Jin Medical International (ZJYL) Common Equity (2022 - 2025)
Historic Common Equity for Jin Medical International (ZJYL) over the last 4 years, with Q1 2025 value amounting to $27.8 million.
- Jin Medical International's Common Equity rose 612.28% to $27.8 million in Q1 2025 from the same period last year, while for Mar 2025 it was $27.8 million, marking a year-over-year increase of 612.28%. This contributed to the annual value of $28.6 million for FY2024, which is 1907.23% up from last year.
- According to the latest figures from Q1 2025, Jin Medical International's Common Equity is $27.8 million, which was up 612.28% from $28.6 million recorded in Q3 2024.
- Over the past 5 years, Jin Medical International's Common Equity peaked at $28.6 million during Q3 2024, and registered a low of $15.2 million during Q3 2022.
- Moreover, its 4-year median value for Common Equity was $25.1 million (2023), whereas its average is $24.2 million.
- Per our database at Business Quant, Jin Medical International's Common Equity skyrocketed by 5738.77% in 2023 and then surged by 612.28% in 2025.
- Jin Medical International's Common Equity (Quarter) stood at $15.2 million in 2022, then skyrocketed by 57.39% to $24.0 million in 2023, then increased by 19.07% to $28.6 million in 2024, then fell by 2.79% to $27.8 million in 2025.
- Its last three reported values are $27.8 million in Q1 2025, $28.6 million for Q3 2024, and $26.2 million during Q1 2024.